FDA approves CTI BioPharma's bone marrow cancer drug

(Reuters) - CTI BioPharma Corp said on Monday the U.S. Food and Drug Administration approved its drug Vonjo (pacritinib) for treating adult patients w...

Related Keywords

Bengaluru ,Karnataka ,India ,Mrinalika Roy ,Rachna Dhanrajani ,Drug Administration ,Biopharma Corp ,Reuters ,Pharma Corp , ,